Table 4 Performance investigation of the biosensor for different cancerous analytes.
Cancer type | Cell type | RI range | Resonance wavelength (nm) | Wavelength sensitivity (nm/RIU) | Amplitude sensitivity (RIU− 1) | Sensor resolution (RIU) | FOM (RIU− 1) |
|---|---|---|---|---|---|---|---|
Skin | Basal | 1.36–1.38 | 0.7–0.78 | 4000 | – 569 | 2.5 × 10− 5 | 74.83 |
Cervical | HeLa | 1.368–1.392 | 0.73–0.94 | 8750 | – 1621.8 | 1.14 × 10− 5 | 163.7 |
Blood | Jurkat | 1.376–1.390 | 0.76–0.91 | 10714.28 | – 1826.77 | 9.33 × 10− 6 | 222.61 |
Adrenal Gland | PC12 | 1.381–1.395 | 0.79–1 | 15,000 | – 1436.24 | 6.66 × 10− 6 | 360.12 |
Breast | MDA-MB-231 | 1.385–1.399 | 0.85–1.3 | 32142.85 | – 736.963 | 3.11 × 10− 6 | 683.32 |
